Andrew Diamond - Feb 15, 2022 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Signature
/s/ Ivy Tseng, Attorney-in-Fact for Andrew Diamond
Stock symbol
ONEM
Transactions as of
Feb 15, 2022
Transactions value $
-$3,428,287
Form type
4
Date filed
10/25/2022, 08:24 PM
Previous filing
Jan 19, 2022
Next filing
Aug 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONEM Common Stock Options Exercise +1.78K +1.63% 111K Feb 15, 2022 Direct F1
transaction ONEM Common Stock Options Exercise $271K +22.3K +20.09% $12.16 133K Oct 24, 2022 Direct
transaction ONEM Common Stock Options Exercise $294K +45K +33.83% $6.54 178K Oct 24, 2022 Direct
transaction ONEM Common Stock Options Exercise $204K +46.9K +26.33% $4.36 225K Oct 24, 2022 Direct
transaction ONEM Common Stock Options Exercise $810K +70.1K +31.17% $11.56 295K Oct 24, 2022 Direct
transaction ONEM Common Stock Sale -$5.01M -293K -99.4% $17.08 1.78K Oct 24, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONEM Restricted Stock Units Options Exercise $0 -1.78K -25.01% $0.00 5.33K Feb 15, 2022 Common Stock 1.78K Direct F1, F4
transaction ONEM Stock Options (Right to buy) Options Exercise $0 -22.3K -18.75% $0.00 96.4K Oct 24, 2022 Common Stock 22.3K $12.16 Direct F5
transaction ONEM Stock Option (Right to Buy) Options Exercise $0 -45K -100% $0.00* 0 Oct 24, 2022 Common Stock 45K $6.54 Direct F5
transaction ONEM Stock Option (Right to Buy) Options Exercise $0 -46.9K -100% $0.00* 0 Oct 24, 2022 Common Stock 46.9K $4.36 Direct F5
transaction ONEM Stock Option (Right to Buy) Options Exercise $0 -70.1K -72.92% $0.00 26K Oct 24, 2022 Common Stock 70.1K $11.56 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
F3 This transaction was executed in multiple trades at prices ranging from $17.06 to $17.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 On 1/15/2021, the reporting person was granted 7,106 restricted stock units vesting in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.
F5 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to the reporting person's continuous service as of each such date.